• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-030
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Vomiting (2144)
Event Date 01/18/2024
Event Type  Injury  
Manufacturer Narrative
Summarized patient outcomes/complications of amplatzer septal occluder were reported in a research article in a subject population with atrial septal defect.Some of the complications reported were headache, vomiting, hospitalization and unexpected medical intervention.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature attachment: headaches in children after transcatheter device closure of atrial septal defects: a single centre experience.
 
Event Description
The article, "headaches in children after transcatheter device closure of atrial septal defects: a single centre experience", was reviewed.The article presented a case study of a 15-year-old, 114.2 kg, female patient with an atrial septal defect (asd) with a maximum diameter of 29mm.It was reported that on an unknown date, a 30mm amplatzer septal occluder was implanted.One week post-procedure, the patient presented to the emergency room with severe unilateral headaches and vomiting.A decision was made to change the patient's post-procedure medication therapy from aspirin to clopidogrel.The article concluded that the study suggested a minimal estimate of 15% as the incidence of headache in children who undergo tdc.This estimate can inform counseling prior to tdc.Determination of the true incidence will require focused prospective data collection.[the primary and corresponding author was joshua griesman, the hospital for sick children, toronto, ontario, canada, with corresponding email: joshua.Griesman@sickkids.Ca].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18744177
MDR Text Key335808674
Report Number2135147-2024-00775
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number9-ASD-030
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age15 YR
Patient SexFemale
Patient Weight114 KG
-
-